Authors
Latest:
Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth HistoryA novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.
Latest:
Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern CaliforniaThis analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.
Latest:
People Experiencing Homelessness in Miami: Insurance Enrollment Rates, Hypertension TrendsPeople experiencing homelessness face significant barriers to health care access, leading to higher rates of hypertension even among those with health insurance.
Latest:
Understanding Insurance Coverage Policies for Incretin Mimetics for Weight ManagementThe high cost of incretin mimetics for weight management limits insurance coverage and potentiates variation in utilization management strategies to control near-term spending.
Latest:
Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung CancerCompared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.
Latest:
Looking Toward the Future: Management of C. Diff InfectionClosing out their discussion on recurrent clostridium difficile infection management, experts share closing thoughts and hopes for the future.
Latest:
Baffled by NAFLD: The Horse Might Be Out of the Barn but Should Not Take Us for a RideAs awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.
Latest:
Overhauling Quality Measurement in the US: Measure What MattersAs the US charts its course through the next political era, it is crucial that we boldly allocate resources and prioritize what truly impacts patients. When faced with complexity, feasibility concerns, or entrenched norms, we must proclaim: “It’s the outcomes, stupid.”
Latest:
Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health OutcomesJason Shafrin, PhD, serves as the vice president of Health Economics at PRECISIONheor, and Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.
Latest:
Impact of the COVID-19 Pandemic on Regular Emergency Department UsersRegular users of the emergency department (ED) transiently reduced ED visits when faced with ED access barriers during the COVID-19 pandemic.
Latest:
Addressing the Psychosocial Impacts of Inflammatory Skin Conditions in Patient CareLauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to atopic dermatitis, psoriasis, and hidradenitis suppurativa.
Latest:
Inpatient Opioid Receipt and Care Experiences for Vaginal DeliveryThe objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.
Latest:
Long-Term Health Care Costs Following COVID-19: Implications for Pandemic PreparednessA difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.
Latest:
Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional MedicarePatients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.
Latest:
Breaking Barriers, Fostering Collaboration at AACR Annual Meeting 2025Program chairs Lillian L. Siu, MD, FAACR, and Matthew G. Vander Heiden, MD, PhD, highlight the cross-disciplinary approach to cancer research and innovation being taken at this year's American Association for Cancer Research (AACR) Annual Meeting.
Latest:
Empiric Segmentation of High-risk Patients: A Structured Literature ReviewData-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.
Latest:
Rheumatoid Arthritis Medication Adherence in a Health System Specialty PharmacyIntegrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.
Latest:
Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS BeneficiariesGalen Shearn-Nance, BS, and Johnie Rose, MD, PhD, of Case Western Reserve University, acknowledge key limitations of their study and prioritize areas for further research.
Latest:
Contributor: In a Fast-Growing and Competitive Dual-Eligible Market, Trust Will Be a Critical DifferentiatorBuilding trust with patients who are dually eligible for Medicaid and Medicare can help to improve their lives as they navigate receiving care to address their clinical and behavioral health needs.
Latest:
Considerations to Increase Rates of Breast Cancer Screening Across PopulationsAuthors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.
Latest:
Impact of Travel Distance on Quality Outcomes in Colorectal CancerThis study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.
Latest:
Cost Savings From an mHealth Tool for Improving Medication AdherenceThe Wellth smartphone app significantly increased medication adherence and lowered unnecessary health care utilization and costs over 9 months among Medicaid beneficiaries who were self-managing chronic conditions.
Latest:
Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should AskPeriodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
Latest:
Outcomes in Patients With IBD Stratified by Risk of Disease ProgressionThis study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.
Latest:
Service Line Care Delivery Model for COVID-19 Patient-Centric CareThe authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.
Latest:
Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory InfectionsThis paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.
Latest:
Trends in Low-Value Cancer Care During the COVID-19 PandemicAmong adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.
Latest:
Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology PracticeReal-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Latest:
Contributor: The Connection Between Gout and CVD Requires Cross-Specialty CollaborationThe Panicos are on a mission to change how we think about gout. Why? As a husband-and-wife DO duo, the Panicos each have a unique perspective on gout and how physicians in their respective fields can better collaborate to help patients who live with this systemic disease.
Latest:
Differences in Telehealth During COVID-19 Between Commercial and Medicaid EnrolleesDifferences in use of telehealth between commercial and Medicaid populations during the COVID-19 pandemic are associated with managed care enrollment.
